3-nitrotyrosine and Idiopathic-Pulmonary-Fibrosis

3-nitrotyrosine has been researched along with Idiopathic-Pulmonary-Fibrosis* in 2 studies

Other Studies

2 other study(ies) available for 3-nitrotyrosine and Idiopathic-Pulmonary-Fibrosis

ArticleYear
Role of thioredoxin nitration in bleomycin-induced pulmonary fibrosis in rats.
    Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:1

    Oxidant stimulation has been suggested to play an important role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Our study aimed to investigate the role and mechanisms of thioredoxin (Trx) nitration during the development of IPF. A rat model of IPF was established by intratracheal instillation of bleomycin (BLM). Male Wistar rats were randomly distributed among the control group and BLM-treated group, in which rats were intratracheally instilled with a single dose of BLM (5.0 mg/kg body mass in 1.0 mL phosphate-buffered saline). At 7 or 28 days after instillation the rats were euthanized. Histopathological and biochemical examinations were performed. The activity and protein level of thioredoxin were assessed. The thioredoxin nitration level was determined using immunoprecipitation and immunoblotting techniques. Our results demonstrated that protein tyrosine nitration increased in the BLM-treated group compared with the control group. Trx activity decreased in the BLM group compared with control group, whereas Trx expression and nitration level increased dramatically in the BLM group compared with the control group. Our results indicated that Trx nitration might be involved in the pathogenesis of IPF.

    Topics: Animals; Bleomycin; Disease Models, Animal; Humans; Hydroxyproline; Idiopathic Pulmonary Fibrosis; Lung; Male; Nitrates; Oxidation-Reduction; Pulmonary Fibrosis; Rats; Rats, Wistar; Thioredoxins; Tyrosine

2016
Increase of nitrosative stress in patients with eosinophilic pneumonia.
    Respiratory research, 2011, Jun-17, Volume: 12

    Exhaled nitric oxide (NO) production is increased in asthma and reflects the degree of airway inflammation. The alveolar NO concentration (Calv) in interstitial pneumonia is reported to be increased. However, it remains unknown whether NO production is increased and nitrosative stress occurs in eosinophilic pneumonia (EP). We hypothesized that nitrosative stress markers including Calv, inducible type of NO synthase (iNOS), and 3-nitrotyrosine (3-NT), are upregulated in EP.. Exhaled NO including fractional exhaled NO (FENO) and Calv was measured in ten healthy subjects, 13 patients with idiopathic pulmonary fibrosis (IPF), and 13 patients with EP. iNOS expression and 3-NT formation were assessed by immunocytochemistory in BALf cells. The exhaled NO, lung function, and systemic inflammatory markers of the EP patients were investigated after corticosteroid treatment for 4 weeks.. The Calv levels in the EP group (14.4 ± 2.0 ppb) were significantly higher than those in the healthy subjects (5.1 ± 0.6 ppb, p < 0.01) and the IPF groups (6.3 ± 0.6 ppb, p < 0.01) as well as the FENO and the corrected Calv levels (all p < 0.01). More iNOS and 3-NT positive cells were observed in the EP group compared to the healthy subject and IPF patient. The Calv levels had significant positive correlations with both iNOS (r = 0.858, p < 0.05) and 3-NT positive cells (r = 0.924, p < 0.01). Corticosteroid treatment significantly reduced both the FENO (p < 0.05) and the Calv levels (p < 0.01). The magnitude of reduction in the Calv levels had a significant positive correlation with the peripheral blood eosinophil counts (r = 0.802, p < 0.05).. These results suggested that excessive nitrosative stress occurred in EP and that Calv could be a marker of the disease activity.

    Topics: Adrenal Cortex Hormones; Aged; Analysis of Variance; Breath Tests; Bronchoalveolar Lavage Fluid; Case-Control Studies; Exhalation; Female; Humans; Idiopathic Pulmonary Fibrosis; Immunohistochemistry; Inflammation Mediators; Japan; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type II; Pulmonary Alveoli; Pulmonary Eosinophilia; Respiratory Function Tests; Stress, Physiological; Time Factors; Treatment Outcome; Tyrosine; Up-Regulation

2011